第二型糖尿病為例－使用長效型胰島素合併口服降血糖藥物轉換混合型胰島素之成效

Type II diabetes as an example - using long-acting insulin combined with oral hypoglycemic agents, the effectiveness of converting mixed insulin

陳政宏(CHEN CHENG HUNG)

指導教授 ： 李桂仁

亞洲大學/資訊學院/生物資訊學系碩士在職專班/碩士(2009年)

摘要

糖尿病至今已成為台灣十大死因的第五位，糖尿病若控制不良會造成許多的併發症，對於醫療支出是一項龐大的負擔，現行健保制度下成本需要考量，利用現有藥物成本降低並達到最好的治療是目前努力的目標。
糖尿病人血糖的控制應該要積極控制，能夠有效控制好血糖減少併發症就是可以節省醫療支出使得健保永續發展。第二型糖尿病患者的治療，使用長效基礎型胰島素加上口服降血糖藥物控制當血糖控制不良患者，轉換成一天兩次預混型胰島素作控制，比較血糖控制效果，及藥物花費成本。
針對使用長效基礎型胰島素加口服降血糖藥物控制患者，轉換成兩次預混型胰島素控制。
固定樣本資料的研究分析，統計方法：成對樣本T檢定，觀察兩種不同藥物之成效，並且在兩組藥物成本分析比較。

關鍵字

胰島素 ； 糖尿病 ； 糖化血色素

並列摘要

Diabetes has become Taiwan's fifth leading cause of death.If poorly controlled, diabetes will cause many complications which are huge burden for medical expenses. The current NHI needs to consider the cost, and it is the goal to reduce the existing drug cost and achieve the best treatment.
The control of diabetes should be a positive control, and good blood glucose control can reduce complications that can make health insurance medical savings sustainable development. The treatment of type II diabetes, long-acting insulin based drug control with oral hypoglycemic for the patients of poor blood glucose control is converted to twice daily premixed insulin control, which is better compared with blood sugar control effects, and costs of drug spending.

並列關鍵字

insulin ； diabetes ； HbA1C

參考文獻

2.2008年國民健康局台灣地區三高追蹤調查報告

1. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB. Diabetes in Asia:epidemiology, risk factors, and pathophysiology. JAMA. 2009 May 27; 301(20):2129-40.

4. American Diabetes Association. Standards of Medical Care in Diabetes—2010.Diabetes Care 2010 33:S11-S61

5. The Diabetes Control and Complications Trial -- Implications for Policy and Practice N Engl J Med. 1993 Sep 30;329(14):1035-6

6. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients Diabetes-Care. 2000 Apr; 23 Suppl 2B21-9